FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003063732> ?p ?o ?g. }

• W2003063732 endingPage "843" @default.
• W2003063732 startingPage "838" @default.
• W2003063732 abstract "Prior studies suggest an increased risk of lymphoma in adults with inflammatory bowel disease (IBD). Cases of lymphoma have also been reported in children with IBD. However, the precise risk of lymphoma in relation to drug exposure has not been ascertained in children. We conducted a single-center, retrospective study of 1560 children and young adults with IBD evaluated at Children's Hospital Boston between 1979 and 2008. Of this group, 186 patients were excluded due to incorrect diagnosis, one-time second-opinion visits, or missing hospital records. The remaining 1374 patients had charts reviewed to determine whether lymphoma developed while they were receiving their clinical care at our institution and the duration of exposure to various IBD medications. The rate of lymphoma was calculated in patient-years of exposure for each class of medications utilized in IBD. Of 1374 patients (741 male; age at diagnosis 12.1 ± 4.0 years; 791 Crohn's disease [CD], 535 ulcerative colitis [UC], 48 IBD unclassified), we identified two patients who developed lymphoma (one Hodgkin, one anaplastic large cell), in 6624 patient-years of follow-up (mean duration follow-up 4.8 years per patient). Both patients were males (ages 12 and 18 years at time of lymphoma onset) and were receiving thiopurines but had not yet received biologics at the time of their cancer diagnosis. They were both treated with chemotherapy and are alive without cancer 32+ and 76+ months since diagnosis. The absolute incidence rate of lymphoma for patients having received thiopurines was 4.5 per 10,000 patient-years compared to the expected rate of 0.58 per 10,000 patient-years, with a standardized incidence ratio (SIR) of 7.51 (95% confidence interval [CI] 0.74–41.98). The overall risk of lymphoma in children with IBD is low, with only two cases seen in our hospital over a 30-year period. The lymphoma risk (as estimated by SIR) in children receiving thiopurines is comparable to that reported in studies of adults. While there may be an increased risk of lymphoma in children treated with thiopurines, the risk did not reach statistical significance in this large cohort." @default.
• W2003063732 created "2016-06-24" @default.
• W2003063732 creator A5023365950 @default.
• W2003063732 creator A5023700189 @default.
• W2003063732 creator A5036335734 @default.
• W2003063732 creator A5052096121 @default.
• W2003063732 creator A5053529786 @default.
• W2003063732 creator A5091551190 @default.
• W2003063732 date "2012-05-01" @default.
• W2003063732 modified "2023-10-10" @default.
• W2003063732 title "Lymphoma risk in children and young adults with inflammatory bowel disease: Analysis of a large single-center cohort" @default.
• W2003063732 cites W2016321388 @default.
• W2003063732 cites W2018771885 @default.
• W2003063732 cites W2021917535 @default.
• W2003063732 cites W2032986095 @default.
• W2003063732 cites W2045123507 @default.
• W2003063732 cites W2048586540 @default.
• W2003063732 cites W2049575817 @default.
• W2003063732 cites W2073537920 @default.
• W2003063732 cites W2080226903 @default.
• W2003063732 cites W2100942700 @default.
• W2003063732 cites W2105532585 @default.
• W2003063732 cites W2122693469 @default.
• W2003063732 cites W2137715127 @default.
• W2003063732 cites W2142612410 @default.
• W2003063732 cites W2145768400 @default.
• W2003063732 cites W2148298419 @default.
• W2003063732 cites W2158865652 @default.
• W2003063732 cites W4252431323 @default.
• W2003063732 cites W4376595875 @default.
• W2003063732 doi "https://doi.org/10.1002/ibd.21844" @default.
• W2003063732 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21887728" @default.
• W2003063732 hasPublicationYear "2012" @default.
• W2003063732 type Work @default.
• W2003063732 sameAs 2003063732 @default.
• W2003063732 citedByCount "49" @default.
• W2003063732 countsByYear W20030637322012 @default.
• W2003063732 countsByYear W20030637322013 @default.
• W2003063732 countsByYear W20030637322014 @default.
• W2003063732 countsByYear W20030637322015 @default.
• W2003063732 countsByYear W20030637322016 @default.
• W2003063732 countsByYear W20030637322017 @default.
• W2003063732 countsByYear W20030637322018 @default.
• W2003063732 countsByYear W20030637322019 @default.
• W2003063732 countsByYear W20030637322020 @default.
• W2003063732 countsByYear W20030637322021 @default.
• W2003063732 countsByYear W20030637322022 @default.
• W2003063732 countsByYear W20030637322023 @default.
• W2003063732 crossrefType "journal-article" @default.
• W2003063732 hasAuthorship W2003063732A5023365950 @default.
• W2003063732 hasAuthorship W2003063732A5023700189 @default.
• W2003063732 hasAuthorship W2003063732A5036335734 @default.
• W2003063732 hasAuthorship W2003063732A5052096121 @default.
• W2003063732 hasAuthorship W2003063732A5053529786 @default.
• W2003063732 hasAuthorship W2003063732A5091551190 @default.
• W2003063732 hasBestOaLocation W20030637321 @default.
• W2003063732 hasConcept C120665830 @default.
• W2003063732 hasConcept C121332964 @default.
• W2003063732 hasConcept C121608353 @default.
• W2003063732 hasConcept C126322002 @default.
• W2003063732 hasConcept C167135981 @default.
• W2003063732 hasConcept C187212893 @default.
• W2003063732 hasConcept C195910791 @default.
• W2003063732 hasConcept C2778260677 @default.
• W2003063732 hasConcept C2779134260 @default.
• W2003063732 hasConcept C2779338263 @default.
• W2003063732 hasConcept C2780073493 @default.
• W2003063732 hasConcept C2780479503 @default.
• W2003063732 hasConcept C61511704 @default.
• W2003063732 hasConcept C71924100 @default.
• W2003063732 hasConcept C72563966 @default.
• W2003063732 hasConceptScore W2003063732C120665830 @default.
• W2003063732 hasConceptScore W2003063732C121332964 @default.
• W2003063732 hasConceptScore W2003063732C121608353 @default.
• W2003063732 hasConceptScore W2003063732C126322002 @default.
• W2003063732 hasConceptScore W2003063732C167135981 @default.
• W2003063732 hasConceptScore W2003063732C187212893 @default.
• W2003063732 hasConceptScore W2003063732C195910791 @default.
• W2003063732 hasConceptScore W2003063732C2778260677 @default.
• W2003063732 hasConceptScore W2003063732C2779134260 @default.
• W2003063732 hasConceptScore W2003063732C2779338263 @default.
• W2003063732 hasConceptScore W2003063732C2780073493 @default.
• W2003063732 hasConceptScore W2003063732C2780479503 @default.
• W2003063732 hasConceptScore W2003063732C61511704 @default.
• W2003063732 hasConceptScore W2003063732C71924100 @default.
• W2003063732 hasConceptScore W2003063732C72563966 @default.
• W2003063732 hasIssue "5" @default.
• W2003063732 hasLocation W20030637321 @default.
• W2003063732 hasLocation W20030637322 @default.
• W2003063732 hasOpenAccess W2003063732 @default.
• W2003063732 hasPrimaryLocation W20030637321 @default.
• W2003063732 hasRelatedWork W2044341494 @default.
• W2003063732 hasRelatedWork W2069424104 @default.
• W2003063732 hasRelatedWork W2070285775 @default.
• W2003063732 hasRelatedWork W2124908533 @default.
• W2003063732 hasRelatedWork W2258300052 @default.
• W2003063732 hasRelatedWork W2408939568 @default.
• W2003063732 hasRelatedWork W2409879998 @default.

• next